- Home
- KW vs DMRA Comparison
KW vs DMRA Comparison
Compare KW & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KW | DMRA |
|---|---|---|
| Founded | 1977 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2007 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KW | DMRA |
|---|---|---|
| Price | $10.84 | $25.52 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $11.00 | ★ $46.00 |
| AVG Volume (30 Days) | ★ 1.3M | 289.2K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.44% | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,633,000.00 | N/A |
| Revenue This Year | $81.79 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.94 | N/A |
| 52 Week Low | $5.98 | $16.50 |
| 52 Week High | $10.99 | $27.68 |
Technical Indicators
Market Signals| Indicator | KW | DMRA |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 52.10 |
| Support Level | $10.82 | $22.92 |
| Resistance Level | $10.97 | $27.68 |
| Average True Range (ATR) | 0.05 | 3.36 |
| MACD | -0.03 | 0.34 |
| Stochastic Oscillator | 12.50 | 82.69 |
Price Performance
Historical ComparisonAbout KW Kennedy-Wilson Holdings Inc.
Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.